PHILADELPHIA, June 9 /PRNewswire/ -- The Sino-American Pharmaceutical Professionals Association -- Greater Philadelphia (SAPA-GP) is holding its 3rd annual conference on Saturday, June 18, at the Science Center of Montgomery County Community College in Blue Bell, Pennsylvania. Entitled “Global Summit on Pharmaceutical and Biotech R&D,” this conference features over 20 prominent thought leaders in the pharmaceutical and biotech industries from the U.S., China and Europe. Included in the program is a large delegation of Chinese industry and government leaders who will address the current status of China’s drug R&D and regulatory policies, and their growing impact on the global pharmaceutical and biotech industry. The conference is followed by the “Shanghai Zhangjiang Night Dinner Reception” sponsored by Zhangjiang Hi-Tech Park.
The conference reflects SAPA’s mission to facilitate scientific exchange and business cooperation between the U.S. and China, and promote career development and networking opportunities for its members and the broader scientific community.
Session 1: Current Trends in World Pharmaceutical and Biotech Industry During the morning session, the SAPA conference will include such notable industry keynote speakers as: * Baruch S. Blumberg, M.D., Ph.D., Nobel Prize Laureate in Medicine, Fox Chase Distinguished Scientist, Senior Advisor to President, Fox Chase Cancer Center, “Global Issues and Infectious Disease: The Worldwide, Hepatitis B Vaccination Campaign” * Anthony Ford-Hutchinson, Ph.D., Executive Vice President, Worldwide Basic Research, Merck Research Laboratories, “Current Challenges and Opportunities of Global Drug Discovery” * Jose V. Sartarelli, Ph.D., Company Group Chairman, Asia- Pacific/Japan/Latin America, Johnson & Johnson Pharmaceuticals Group, “Prospects for Asia-Pacific and China: A World of Possibilities” * Robert R. Ruffolo, Jr., Ph.D., President, Research & Development, Wyeth Pharmaceuticals, Senior Vice President, Wyeth Corporation, “Strategies to Integrate Discovery, Development and Global Marketing” Session 2: Global R&D Alliance and Outsourcing In addition to the morning plenary session the conference will hold two afternoon sessions. These sessions will include such notable industry and academic speakers as: * Ling Chen, M.D., Ph.D., Director-General, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences “An East-West Partnership in Innovative Medicine, Has the Time Arrived?” * Ling Su, Ph.D., Director, Medical and International Pharma Development, Shanghai Roche Pharmaceuticals Ltd “Global Drug Clinical Development in Asia and China” Session 3: Chinese Biotech and Pharma: Challenges and Opportunities * Hongguang Wang, Ph.D., Director-General, China National Center for Biotechnology Development, The Ministry of Science and Technology of China “Biotechnology and Bioindustry in China” * Ming-De Yu, Executive Chairman, China Worldbest Life Industry Co. Executive Chairman, China Pharmaceutical Enterprise Management Association, “Current Status and Prospects of Chinese Pharmaceutical Industry”
SAPA was founded in 1993 as a non-profit organization and now has a membership base of more than 3000, most of whom are highly educated pharmaceutical and biotechnology professionals. It is headquartered in the Greater New York area (NJ/NY/CT) with three regional chapters in the US (SAPA- GP, SAPA-NE and SAPA-WEST), and four sponsor cities in China.
For a detailed conference program and registration information, please visit SAPA-GP’s home page at http://www.sapa-gp.org or contact: conference@sapa-gp.org.
(Press Release prepared by Daniel Williams, Co-founder, Leadership Communications Inc., 781-784-2705, dan@tolead.com)
Sino-American Pharmaceutical Professionals Association
CONTACT: Daniel Williams, Co-founder for Sino-American PharmaceuticalProfessionals Association, +1-781-784-2705, dan@tolead.com
Web site: http://www.sapa-gp.org/
